Virtu Financial LLC Aridis Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$0.16 - $0.4 $1,889 - $4,723	11,809 New	11,809 $3,000
Q1 2022 May 17, 2022	SELL	$1.33 - $2.59 $16,226 - $31,598	-12,200 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$2.0 - $3.65 $24,400 - $44,530	12,200 New	12,200 $28,000

50.2K

Ticker ARDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,701,600
Description
Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.